Trop2-Based Antibody–Drug Conjugates: Emerging Strategy and Progress in Triple-Negative Breast Cancer Therapy.

Simple Summary: With the aim of providing evidence-based insights for improved prognosis in TNBC patients, this article conducts a systematic review of the clinical research progress of Trop2-targeted ADCs. Trop2-targeted therapies are set to become a cornerstone of precision medicine for solid tumo...

Full description

Bibliographic Details

Published in:	Current Oncology Vol. 31; no. 2; pp. 92 - 110
Main Authors:	Li, Tong, Zhang, Tao, Dang, Yongxia, Lin, Yilin, Li, Xiaotong, Ling, Xiaoling
Format:	Journal Article
Published:	MDPI Feb2026
Online Access:	View this record in EBSCOhost